This Article Abstract Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Uguccioni, M. Articles by Baggiolini, M. Search for Related Content PubMed PubMed Citation Articles by Uguccioni, M. Articles by Baggiolini, M.

(American Journal of Pathology. 1999;155:331-336.)
© 1999 American Society for Investigative Pathology

Short Communication

Increased Expression of IP-10, IL-8, MCP-1, and MCP-3 in Ulcerative Colitis

Mariagrazia Uguccioni^*, Paolo Gionchetti, Davide F. Robbiani^*, Fernando Rizzello, Sabrina Peruzzo, Massimo Campieri and Marco Baggiolini^*

From the Theodor Kocher Institute,^*
University of Bern, Bern, Switzerland; and the Department of Internal Medicine and Gastroenterology,
University of Bologna, Bologna, Italy

	Abstract

Top Abstract Introduction Materials and Methods Results Discussion References

 
Chemokines are thought to be important for the recruitment of granulocytes and mononuclear cells and thus for the maintenance of inflammation in ulcerative colitis (UC). We have studied the expression of interferon- inducible protein-10 (IP-10), interleukin-8 (IL-8), monocyte chemoattractant protein (MCP)-1, MCP-3, and macrophage inflammatory protein (MIP)-1 in UC patients and control individuals to assess the role of these chemokines in disease progression. Colonic biopsies were taken endoscopically from patients and controls, frozen immediately and subsequently stained for IP-10, IL-8, MCP-1, MCP-3, and MIP-1 in serial sections. Cells infiltrating the lamina propria but not epithelial cells express the analyzed chemokines. They were differentiated and counted, and chemokine-expressing cells were quantified by image analysis. The percentage of cells expressing IP-10, IL-8, MCP-1, and MCP-3 was significantly enhanced in all UC samples as compared to controls. Expression in the controls was borderline, except for IP-10. No expression of MIP-1 was found in controls and UC. IP-10 was also markedly expressed in the mucosa of control biopsies and therefore could have a role in activated T lymphocytes' recruitment into the healthy mucosa.

	Introduction

Top Abstract Introduction Materials and Methods Results Discussion References

The relationship between clinical activity, endoscopic severity, and chemokine production in inflammatory bowel diseases has been repeatedly investigated.¹ Several studies have provided evidence for the role of interleukin-8 (IL-8) in mediating infiltration of neutrophils into the gut wall.^6-11 Monocyte chemoattractant protein (MCP)-1, on the other hand, was reported to elicit the infiltration of monocytes into the colonic mucosa of patients affected by UC.^12-14

In the present study we analyzed the expression of five chemokines with distinct, but overlapping target selectivity to gain information on their role in UC. In addition to the chemokines that were analyzed previously we have included interferon- inducible protein-10 (IP-10), a selective attractant of activated T lymphocytes, and MCP-3, a powerful CC chemokine.⁵ Serial sections from colonic biopsies, which were taken endoscopically from assessing UC disease activity, were examined by immunohistochemistry and evaluated by image analysis. All biopsies stained positively for IP-10, IL-8, MCP-1, and MCP-3 but not for macrophage inflammatory protein-1 (MIP-1), and the number of chemokine-expressing cells increased significantly in dependence on disease activity.

	Materials and Methods

Top Abstract Introduction Materials and Methods Results Discussion References

 
Patients

Colonic biopsies were obtained from 30 consenting patients with UC (9 female and 21 male; median age 40 years; range, 22–63 years) undergoing colonoscopy for diagnostic purposes as approved by the institutional review board of the Bologna University Hospital. The diagnoses were based on clinical, radiological, endoscopic, and histological criteria.

Disease duration, histological disease activity, and drug treatment are listed for each patient in Table 1 . Five additional colonic biopsies were obtained as controls from consenting patients undergoing endoscopy to rule out a neoplastic disease. Endoscopic appearance of the colonic mucosa was assessed according to the criteria of Baron et al.¹⁵ Histological disease activity was assessed according to the criteria of Truelove and Richard.¹⁶ A single pathologist blinded to patient identification, clinical status, and treatment assigned histological disease activity index scores as follows: 0, normal; 1, chronic inflammatory cell infiltrate in lamina propria; 2, mild crypt injury with acute cell infiltrate, some crypt abscesses; 3, marked crypt destruction with crypt abscesses and ulceration. Patients with UC were divided into two groups according to histological disease activity scores. Grade 1 corresponds to patients with inactive disease (n = 17) and grade 2/3 corresponds to patients with mild to moderate or severe disease activity (n = 13).

Tissue samples were immediately embedded in OCT compound (Sakura Inc., Torrance, CA), frozen in liquid nitrogen, and stored at -70°C. Cryostatic sections 4 µm thick were fixed and stained as described.¹⁷ Endogenous peroxidase activity in colon mucosa was blocked at room temperature for 1 hour with 1% hydrogen peroxide in phosphate buffered saline with 0.1% saponin. Serial sections were incubated overnight with 5 µg/ml of a monoclonal antibody (mAb) against IP-10, IL-8, MCP-1, MCP-3, or MIP-1.¹⁸ Lymphocytes, macrophages, and neutrophils were identified using anti-CD3 at 1:50, anti-CD68 at 1:100, and anti-neutrophil elastase at 1:200 (all from Dako, Glostrup, Denmark). Species and isotype-matched immunoglobulins (Sigma, St. Louis, MO) were used as controls. After washing, the slides were incubated for 30 minutes with biotin-labeled sheep anti-mouse antibody (Amersham, Arlington Heights, IL) at 1:800. After additional washes, the slides were incubated for 30 minutes with streptavidin-biotin-horseradish peroxidase (Dako). All incubations were performed at room temperature. The color reaction was developed with 3-amino-9-ethyl-carbazole (Sigma). The slides were counterstained with Mayer's hematoxylin. All chemokine mAbs were kindly provided by LeukoSite, Inc. (Cambridge, MA). Their specificity was assessed by absorption. The mAbs were incubated overnight at 4°C with the respective chemokine, and the supernatants of this reaction were then used for the immunohistochemistry procedure.

Analysis of Tissue Sections

The cells expressing chemokines in the lamina propria were evaluated using the NIH Image analyzer. All epithelial or intraepithelial cells were excluded. Several magnification fields (20x to 40x) of each chemokine-stained section were analyzed. Two acquisitions per field were made, one in bright field for counting the total number of cells and the second in bright field with an interpose blue filter (Kodak Wratten 47B) for enhancing the brown peroxidase product. The second image was used for counting chemokine-positive cells. The same method was used to analyze cells positive for CD68, CD3, and elastase. The results are expressed as percentage of positive cells with respect to the total number of cells counted.

Statistical Analysis

The parameters were submitted to the Kruskal-Wallis test, a nonparametric one-way analysis of variance. After the global analysis, multiple comparisons between pairs of groups were carried out according to Dunn's test.¹⁹

	Results

Top Abstract Introduction Materials and Methods Results Discussion References

 
Chemokine expression was analyzed in serial sections of biopsies from UC patients and controls. The intestinal mucosa of control biopsies was free of pathological changes and contained on average in the lamina propria 41 x 10^-4 cells/µm². Much higher numbers of cells were counted in samples from UC patients. The infiltrate consisted mainly of lymphocytes (CD3-positive cells) and macrophages (CD68-positive cells) (Table 2) . In the lamina propria an average of 52 x 10^-4cells/µm² and 57 x 10^-4cells/µm² was observed in grade 1 and grade 2/3 biopsies, respectively. Cell-associated positivity for IP-10, IL-8, MCP-1, and MCP-3 was found in all UC samples in the lamina propria, but not in the epithelium (Figure 1) . Staining for MIP-1, by contrast, was not observed. The percentage of chemokine-positive cells in the three groups, as obtained by image analysis, is shown in Figure 2 .

View larger version (175K): [in this window] [in a new window]   Figure 1. Micrograph of serial sections from a representative UC colonic mucosa stained for IP-10, IL-8, MCP-1, and MCP-3. Higher magnification of chemokine-positive cells are shown in the insets. Original magnifications, x20 (IP-10 and IL-8) and x40 (MCP-1 and MCP-3).

View larger version (28K): [in this window] [in a new window]   Figure 2. Percentage of IP-10, IL-8, MCP-1, and MCP-3 positive cells in the lamina propria of UC colonic mucosa and controls. Mean ± SE of each group studied is shown. The asterisk represents a significant difference between groups (P < 0.01).

IL-8-positive cells were found in all of the UC samples and only rarely in the controls. In the lamina propria, IL-8-positive cells amounted to 0.25% in control, 11% in UC grade 1, and 27% in UC grade 2/3 samples (global value from Kruskall-Wallis test 17.12, P < 0.01). Highly significant differences (P < 0.01) were observed between controls and UC, and between UC grade 1 and UC grade 2/3 (Figure 2) .

MCP-1- and MCP-3-positive cells were found in all controls and UC samples, but the percentages were lower than for cells expressing IP-10 or IL-8. The incidence of MCP-1- and MCP-3-positive cells in the lamina propria was 0.7 and 1.2% in controls, 6.9 and 6.8% in UC grade 1, and 14.6 and 14.8% in UC grade 2/3. For MCP-1, the global value from the Kruskall-Wallis test was 14.38 (P < 0.01); for MCP-3, the value was 15.80 (P < 0.01). For both chemokines the values were significantly higher in UC grade 2/3 than in UC grade 1 and controls (P < 0.01), but the differences between UC grade 1 and controls were not statistically significant (Figure 2) .

Immunohistological staining of serial sections for chemokines, macrophages, neutrophils, and T lymphocytes indicated that the mononuclear cells were the major source of the chemokine. In particular, IP-10 and, to a lesser extent, IL-8 were also associated with CD3-positive cell areas. IL-8 expression was occasionally observed in endothelial cells of UC grade 2/3, but no chemokine was detected in epithelial cells.

	Discussion

Top Abstract Introduction Materials and Methods Results Discussion References

 
We have analyzed the expression of five chemokines in the lamina propria of colonic biopsies taken from patients with UC and have found that their expression increases with disease activity. The chemokines were chosen because they are frequently present in inflamed tissues and are known to attract different types of leukocytes that are found in the lesions. IL-8 is the major attractant and activator of neutrophils.^20-22 IP-10 selectively attracts activated T lymphocytes, which are the only inflammatory cells expressing the chemokine receptor CXCR3.²³ MCP-1, MCP-3, and MIP-1 attract monocytes and activated lymphocytes via different receptors, CCR1, CCR2, and CCR5.^24-28

Several papers have reported chemokine expression in chronic inflammatory diseases of the colon. They showed that chemokines acting on neutrophils and mononuclear cells are found most frequently in UC and Crohn's disease, but value of the data was limited by the small number of patients and the lack of quantitative evaluation of the chemokines expressed and the inflammatory cells present.²⁹

In addition, most studies were performed with tissue samples obtained by resection from patients with end-stage disease. We have studied a large population of UC patients who were treated only with 5-aminosalicylic acid or Sulfasalazine. All samples were obtained by endoscopy in the first days of disease relapse, thus ensuring a careful staging and homogeneity of the groups. In addition to the chemokines analyzed previously, we have included IP-10, a selective attractant of activated T lymphocytes,²³ and MCP-3, a powerful CC chemokine that acts on monocytes, activated T lymphocytes, eosinophils, and basophils.^30-34

By analyzing the cells infiltrating the lamina propria we found that IL-8, MCP-1, and MCP-3, which are barely detectable in normal tissue, are significantly increased not only in active but also in clinically inactive disease. A correlation of IL-8 expression and number of positive cells with the histological stage of the disease was formerly reported for samples obtained by surgical resection.^6,8 In addition, IL-8 was detected in homogenates of surgery samples from UC patients with different degrees of inflammation.⁹ Higher expression of MCP-1 was also reported and suggested to derive mainly from cells of the lamina propria and the epithelia.^12,14 Data on the expression of MCP-1 by epithelial cells are, however, contradictory.¹³ In the present study epithelial cells were always negative, although it was shown previously that freshly isolated epithelial cells can produce IL-8 and MCP-1.^35-37 The expression of MCP-1 and MCP-3 was virtually identical in terms of the number of positive cells and their distribution. Although always considerably lower than that of IP-10 and IL-8, the expression of both MCPs was always significantly enhanced in mucosal samples from patients with severe disease.

In control biopsies few leukocytes were observed and positivity for IL-8, MCP-1, or MCP-3 was extremely rare. The high percentage of IP-10-positive cells observed in controls suggests that in contrast to IL-8, MCP-1, and MCP-3, IP-10 is normally expressed by some resident cells. IP-10 may be involved in the recruitment of activated lymphocytes into the normal mucosa. It is interesting, however, that in active UC, IP-10 expression was always up-regulated to a greater extent than that of other chemokines.

	Acknowledgements

 
We thank Dr. Beatrice Dewald (Theodor Kocher Institute, University of Bern) for critical reading of the manuscript and Dr. Antoinette Wetterwald (Institute for Clinical Research, University of Bern) for advice on histology.

	Footnotes

 
Address reprint requests to Prof. Marco Baggiolini, Theodor Kocher Institute, Freiestrasse 13012, Bern, Switzerland. E-mail: marco.baggiolini{at}tki.unibe.ch

Supported in part by the Swiss National Science Foundation.

Accepted for publication April 14, 1999.

	References

Top Abstract Introduction Materials and Methods Results Discussion References

 

1. Fiocchi C: Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998, 115:182-205[Medline]
2. MacDermott RP, Sanderson IR, Reinecker HC: The central role of chemokines (chemotactic cytokines) in the immunopathogenesis of ulcerative colitis and Crohn's disease. Inflam Bowel Dis 1998, 4:54-67[Medline]
3. Luster AD: Chemokines: chemotactic cytokines that mediate inflammation. N Engl J Med 1998, 338:436-445[Free Full Text]
4. Baggiolini M, Dewald B, Moser B: Human chemokines: an update. Annu Rev Immunol 1997, 15:675-705[Medline]
5. Baggiolini M: Chemokines and leukocyte traffic. Nature 1998, 392:565-568[Medline]
6. Grimm MC, Elsbury SKO, Pavli P, Doe WF: Interleukin 8: cells of origin in inflammatory bowel disease. Gut 1996, 38:90-98[Abstract/Free Full Text]
7. Mitsuyama K, Toyonaga A, Sasaki E, Watanabe K, Tateishi H, Nishiyama T, Saiki T, Ikeda H, Tsuruta O, Tanikawa K: IL-8 as an important chemoattractant for neutrophils in ulcerative colitis and Crohn's disease. Clin Exp Immunol 1994, 96:432-436[Medline]
8. Mazzucchelli L, Hauser C, Zgraggen K, Wagner H, Hess M, Laissue JA, Mueller C: Expression of interleukin-8 gene in inflammatory bowel disease is related to the histological grade of active inflammation. Am J Pathol 1994, 144:997-1007[Abstract]
9. Daig R, Andus T, Aschenbrenner E, Falk W, Schölmerich J, Gross V: Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease. Gut 1996, 38:216-222[Abstract/Free Full Text]
10. Nielsen OH, Rüdiger N, Gaustadnes M, Horn T: Intestinal interleukin-8 concentration and gene expression in inflammatory bowel disease. Scand J Gastroenterol 1997, 32:1028-1034[Medline]
11. Ina K, Kusugami K, Yamaguchi T, Imada A, Hosokawa T, Ohsuga M, Shinoda M, Ando T, Ito K, Yokoyama Y: Mucosal interleukin-8 is involved in neutrophil migration and binding to extracellular matrix in inflammatory bowel disease. Am J Gastroenterol 1997, 92:1342-1346[Medline]
12. Reinecker H-C, Loh EY, Ringler DJ, Mehta A, Rombeau JL, MacDermott RP: Monocyte-chemoattractant protein 1 gene expression in intestinal epithelial cells and inflammatory bowel disease mucosa. Gastroenterology 1995, 108:40-50[Medline]
13. Mazzucchelli L, Hauser C, Zgraggen K, Wagner HE, Hess MW, Laissue JA, Mueller C: Differential in situ expression of the genes encoding the chemokines MCP-1, and RANTES in human inflammatory bowel disease. J Pathol 1996, 178:201-206[Medline]
14. Grimm MC, Elsbury SKO, Pavli P, Doe WF: Enhanced expression and production of monocyte chemoattractant protein-1 in inflammatory bowel disease mucosa. J Leukoc Biol 1996, 59:804-812[Abstract]
15. Baron JH, Connel AM, Lennard Jones JE: Variation betwwen observers in describing mucosal appearances in proctocolitis. Br Med J 1964, 1:89-92
16. Truelove SC, Richard WCD: Biopsy studies in ulcerative colitis. Br Med J 1956, 1:1315-1318
17. Ulfgren A-K, Lindblad S, Klareskog L, Andersson J, Andersson U: Detection of cytokine producing cells in the synovial membrane from patients with rheumatoid arthritis. Ann Rheum Dis 1995, 54:654-661[Abstract/Free Full Text]
18. Sasseville VG, Smith MM, Mackay CR, Pauley DR, Mansfield KG, Ringler DJ, Lackner AA: Chemokine expression in simian immunodeficiency virus-induced AIDS encephalitis. Am J Pathol 1996, 149:1459-1467[Abstract]
19. Dunn OJ: Multiple comparisons using rank sums. Tecnometrics 1964, 6:241-252
20. Mahida YR, Ceska M, Effenberger F, Kurlak L, Lindley I, Hawkey CJ: Enhanced synthesis of neutrophil-activating peptide-1/interleukin-8 in active ulcerative colitis. Clin Sci 1992, 82:273-275[Medline]
21. Raab Y, Gerdin B, Ahlstedt S, Hällgren R: Neutrophil mucosal involvement is accompanied by enhanced local production of interleukin-8 in ulcerative colitis. Gut 1993, 34:1203-1206[Abstract/Free Full Text]
22. Keshavarzian A, Fusunyan RD, Jacyno M, Winship D, MacDermott RP, Sanderson IR: Increased interleukin-8 (IL-8) in rectal dialysate from patients with ulcerative colitis: evidence for a biological role for IL-8 in inflammation of the colon. Am J Gastroenterol 1999, 94:704-712[Medline]
23. Loetscher M, Gerber B, Loetscher P, Jones SA, Piali L, Clark-Lewis I, Baggiolini M, Moser B: Chemokine receptor specific for IP10 and Mig: structure, function, and expression in activated T-lymphocytes. J Exp Med 1996, 184:963-969[Abstract/Free Full Text]
24. Uguccioni M, D'Apuzzo M, Loetscher M, Dewald B, Baggiolini M: Actions of the chemotactic cytokines MCP-1, MCP-2, MCP-3, RANTES, MIP-1 and MIP-1ß on human monocytes. Eur J Immunol 1995, 25:64-68[Medline]
25. Loetscher P, Seitz M, Baggiolini M, Moser B: Interleukin-2 regulates CC chemokine receptor expression and chemotactic responsiveness in T lymphocytes. J Exp Med 1996, 184:569-577[Abstract/Free Full Text]
26. Samson M, Labbe O, Mollereau C, Vassart G, Parmentier M: Molecular cloning and functional expression of a new human CC-chemokine receptor gene. Biochemistry 1996, 35:3362-3367[Medline]
27. Raport CJ, Gosling J, Schweickart VL, Gray PW, Charo IF: Molecular cloning and functional characterization of a novel human CC chemokine receptor (CCR5) for RANTES, MIP-1ß, and MIP-1. J Biol Chem 1996, 271:17161-17166[Abstract/Free Full Text]
28. Combadiere C, Ahuja SK, Tiffany HL, Murphy PM: Cloning and functional expression of CC CKR5, a human monocyte CC chemokine receptor selective for MIP-1, MIP-1ß, and RANTES. J Leukoc Biol 1996, 60:147-152[Abstract]
29. Grimm MC, Doe WF: Chemokine in inflammatory bowel disease mucosa: expression of RANTES, macrophage inflammatory protein (MIP)-1, MIP-1ß, and -interferon-inducible protein-10 by macrophages, lymphocytes, endothelial cells, and granulomas. Inflamm Bowel Dis 1996, 2:88-96
30. Van Damme J, Proost P, Lenaerts J-P, Opdenakker G: Structural and functional identification of two human, tumor-derived monocyte chemotactic proteins (MCP-2 and MCP-3) belonging to the chemokine family. J Exp Med 1992, 176:59-65[Abstract/Free Full Text]
31. Minty A, Chalon P, Guillemot JC, Kaghad M, Liauzun P, Magazin M, Miloux B, Minty C, Ramond P, Vita N, Lupker J, Shire D, Ferrara P, Caput D: Molecular cloning of the MCP-3 chemokine gene and regulation of its expression. Eur Cytokine Netw 1993, 4:99-110[Medline]
32. Noso N, Proost P, Van Damme J, Schröder J-M: Human monocyte chemotactic proteins-2 and 3 (MCP-2 and MCP-3) attract human eosinophils and desensitize the chemotactic responses towards RANTES. Biochem Biophys Res Commun 1994, 200:1470-1476[Medline]
33. Loetscher P, Seitz M, Clark-Lewis I, Baggiolini M, Moser B: The monocyte chemotactic proteins, MCP-1, MCP-2 and MCP-3, are major attractants for human CD4⁺ and CD8⁺ T lymphocytes. FASEB J 1994, 8:1055-1060[Abstract]
34. Dahinden CA, Geiser T, Brunner T, von Tscharner V, Caput D, Ferrara P, Minty A, Baggiolini M: Monocyte chemotactic protein 3 is a most effective basophil- and eosinophil-activating chemokine. J Exp Med 1994, 179:751-756[Abstract/Free Full Text]
35. Yang SK, Eckmann L, Panja A, Kagnoff M: Differential and regulated expression of CXC, CC, and C chemokines by human colon epithelial cells. Gastroenterology 1997, 113:1214-1223[Medline]
36. Jung HC, Eckmann L, Yang S-K, Panja A, Fierer J, Morzycka-Wroblewska E, Kagnoff MF: A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J Clin Invest 1995, 95:55-65
37. Gibson P, Rosella O: Interleukin 8 secretion by colonic crypt cells in vitro: response to injury suppressed by butyrate and enhanced in inflammatory bowel disease. Gut 1995, 37:536-543[Abstract/Free Full Text]

This article has been cited by other articles:

				M. Hori, H. Nobe, K. Horiguchi, and H. Ozaki MCP-1 targeting inhibits muscularis macrophage recruitment and intestinal smooth muscle dysfunction in colonic inflammation Am J Physiol Cell Physiol, February 1, 2008; 294(2): C391 - C401. [Abstract] [Full Text] [PDF]

				P. Buanne, E. Di Carlo, L. Caputi, L. Brandolini, M. Mosca, F. Cattani, L. Pellegrini, L. Biordi, G. Coletti, C. Sorrentino, et al. Crucial pathophysiological role of CXCR2 in experimental ulcerative colitis in mice J. Leukoc. Biol., November 1, 2007; 82(5): 1239 - 1246. [Abstract] [Full Text] [PDF]

				L. Zhao, M.-J. Kwon, S. Huang, J. Y. Lee, K. Fukase, N. Inohara, and D. H. Hwang Differential Modulation of Nods Signaling Pathways by Fatty Acids in Human Colonic Epithelial HCT116 Cells J. Biol. Chem., April 20, 2007; 282(16): 11618 - 11628. [Abstract] [Full Text] [PDF]

				S. E. Crown, Y. Yu, M. D. Sweeney, J. A. Leary, and T. M. Handel Heterodimerization of CCR2 Chemokines and Regulation by Glycosaminoglycan Binding J. Biol. Chem., September 1, 2006; 281(35): 25438 - 25446. [Abstract] [Full Text] [PDF]

				Y. Kawauchi, K. Suzuki, S. Watanabe, S. Yamagiwa, H. Yoneyama, G. D. Han, S. S. Palaniyandi, P. T. Veeraveedu, K. Watanabe, H. Kawachi, et al. Role of IP-10/CXCL10 in the progression of pancreatitis-like injury in mice after murine retroviral infection. Am J Physiol Gastrointest Liver Physiol, August 1, 2006; 291(2): G345 - G354. [Abstract] [Full Text] [PDF]

				S. Y. Eum, G. B. Rha, B. Hennig, and M. Toborek c-Src Is the Primary Signaling Mediator of Polychlorinated Biphenyl-Induced Interleukin-8 Expression in a Human Microvascular Endothelial Cell Line Toxicol. Sci., July 1, 2006; 92(1): 311 - 320. [Abstract] [Full Text] [PDF]

				G. D. Han, K. Suzuki, H. Koike, K. Suzuki, H. Yoneyama, S. Narumi, F. Shimizu, and H. Kawachi IFN-Inducible Protein-10 Plays a Pivotal Role in Maintaining Slit-Diaphragm Function by Regulating Podocyte Cell-Cycle Balance J. Am. Soc. Nephrol., February 1, 2006; 17(2): 442 - 453. [Abstract] [Full Text] [PDF]

				K. Abel, D. M. Rocke, B. Chohan, L. Fritts, and C. J. Miller Temporal and Anatomic Relationship between Virus Replication and Cytokine Gene Expression after Vaginal Simian Immunodeficiency Virus Infection J. Virol., October 1, 2005; 79(19): 12164 - 12172. [Abstract] [Full Text] [PDF]

				S Danese and A Gasbarrini Chemokines in inflammatory bowel disease J. Clin. Pathol., October 1, 2005; 58(10): 1025 - 1027. [Full Text] [PDF]

				D Kawashima, N Oshitani, Y Jinno, K Watanabe, S Nakamura, K Higuchi, and T Arakawa Augmented expression of secondary lymphoid tissue chemokine and EBI1 ligand chemokine in Crohn's disease J. Clin. Pathol., October 1, 2005; 58(10): 1057 - 1063. [Abstract] [Full Text] [PDF]

				J. K. S. Ko and C.-H. Cho The Diverse Actions of Nicotine and Different Extracted Fractions from Tobacco Smoke against Hapten-Induced Colitis in Rats Toxicol. Sci., September 1, 2005; 87(1): 285 - 295. [Abstract] [Full Text] [PDF]

				L. Hu and T. E. Hickey Campylobacter jejuni Induces Secretion of Proinflammatory Chemokines from Human Intestinal Epithelial Cells Infect. Immun., July 1, 2005; 73(7): 4437 - 4440. [Abstract] [Full Text] [PDF]

				S J Connor, N Paraskevopoulos, R Newman, N Cuan, T Hampartzoumian, A R Lloyd, and M C Grimm CCR2 expressing CD4+ T lymphocytes are preferentially recruited to the ileum in Crohn's disease Gut, September 1, 2004; 53(9): 1287 - 1294. [Abstract] [Full Text] [PDF]

				G. D. Han, H. Koike, T. Nakatsue, K. Suzuki, H. Yoneyama, S. Narumi, N. Kobayashi, P. Mundel, F. Shimizu, and H. Kawachi IFN-Inducible Protein-10 Has a Differential Role in Podocyte during Thy 1.1 Glomerulonephritis J. Am. Soc. Nephrol., December 1, 2003; 14(12): 3111 - 3126. [Abstract] [Full Text] [PDF]

				M. J. Smit, P. Verdijk, E. M. H. van der Raaij-Helmer, M. Navis, P. J. Hensbergen, R. Leurs, and C. P. Tensen CXCR3-mediated chemotaxis of human T cells is regulated by a Gi- and phospholipase C-dependent pathway and not via activation of MEK/p44/p42 MAPK nor Akt/PI-3 kinase Blood, September 15, 2003; 102(6): 1959 - 1965. [Abstract] [Full Text] [PDF]

				U. P. Singh, S. Singh, D. D. Taub, and J. W. Lillard Jr. Inhibition of IFN-{gamma}-Inducible Protein-10 Abrogates Colitis in IL-10-/- Mice J. Immunol., August 1, 2003; 171(3): 1401 - 1406. [Abstract] [Full Text] [PDF]

				M. H. Myles, R. S. Livingston, B. A. Livingston, J. M. Criley, and C. L. Franklin Analysis of Gene Expression in Ceca of Helicobacter hepaticus-Infected A/JCr Mice before and after Development of Typhlitis Infect. Immun., July 1, 2003; 71(7): 3885 - 3893. [Abstract] [Full Text] [PDF]

				J. Heidemann, H. Ogawa, M. B. Dwinell, P. Rafiee, C. Maaser, H. R. Gockel, M. F. Otterson, D. M. Ota, N. Lugering, W. Domschke, et al. Angiogenic Effects of Interleukin 8 (CXCL8) in Human Intestinal Microvascular Endothelial Cells Are Mediated by CXCR2 J. Biol. Chem., February 28, 2003; 278(10): 8508 - 8515. [Abstract] [Full Text] [PDF]

				N. Fernandez, M. Renedo, C. Garcia-Rodriguez, and M. Sanchez Crespo Activation of Monocytic Cells Through Fc{gamma} Receptors Induces the Expression of Macrophage-Inflammatory Protein (MIP)-1{alpha}, MIP-1{beta}, and RANTES J. Immunol., September 15, 2002; 169(6): 3321 - 3328. [Abstract] [Full Text] [PDF]

				T. S. Olson and K. Ley Chemokines and chemokine receptors in leukocyte trafficking Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2002; 283(1): R7 - R28. [Abstract] [Full Text] [PDF]

				X.-Z. Shang, B.-C. Chiu, V. Stolberg, N. W. Lukacs, S. L. Kunkel, H. S. Murphy, and S. W. Chensue Eosinophil Recruitment in Type-2 Hypersensitivity Pulmonary Granulomas : Source and Contribution of Monocyte Chemotactic Protein-3 (CCL7) Am. J. Pathol., July 1, 2002; 161(1): 257 - 266. [Abstract] [Full Text] [PDF]

				M. D. Vrees, V. E. Pricolo, F. M. Potenti, and W. Cao Abnormal Motility in Patients With Ulcerative Colitis: The Role of Inflammatory Cytokines Arch Surg, April 1, 2002; 137(4): 439 - 446. [Abstract] [Full Text] [PDF]

				K. Kai, K. Nasu, S. Nakamura, J. Fukuda, M. Nishida, and I. Miyakawa Expression of interferon-{gamma}-inducible protein-10 in human endometrial stromal cells Mol. Hum. Reprod., February 1, 2002; 8(2): 176 - 180. [Abstract] [Full Text] [PDF]

				B. Siegmund, G. Fantuzzi, F. Rieder, F. Gamboni-Robertson, H.-A. Lehr, G. Hartmann, C. A. Dinarello, S. Endres, and A. Eigler Neutralization of interleukin-18 reduces severity in murine colitis and intestinal IFN-gamma and TNF-alpha production Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2001; 281(4): R1264 - R1273. [Abstract] [Full Text] [PDF]

				B. Qiu, K. A. Frait, F. Reich, E. Komuniecki, and S. W. Chensue Chemokine Expression Dynamics in Mycobacterial (Type-1) and Schistosomal (Type-2) Antigen-Elicited Pulmonary Granuloma Formation Am. J. Pathol., April 1, 2001; 158(4): 1503 - 1515. [Abstract] [Full Text] [PDF]

				M. N. Ajuebor, C. M. Hogaboam, S. L. Kunkel, A. E. I. Proudfoot, and J. L. Wallace The Chemokine RANTES Is a Crucial Mediator of the Progression from Acute to Chronic Colitis in the Rat J. Immunol., January 1, 2001; 166(1): 552 - 558. [Abstract] [Full Text] [PDF]

				M. Fujita, Y. Furukawa, Y. Nagasawa, M. Ogawa, and Y. Nakamura Down-Regulation of Monocyte Chemotactic Protein-3 by Activated {beta}-Catenin Cancer Res., December 1, 2000; 60(23): 6683 - 6687. [Abstract] [Full Text]

				M. T. Liu, B. P. Chen, P. Oertel, M. J. Buchmeier, D. Armstrong, T. A. Hamilton, and T. E. Lane Cutting Edge: The T Cell Chemoattractant IFN-Inducible Protein 10 Is Essential in Host Defense Against Viral-Induced Neurologic Disease J. Immunol., September 1, 2000; 165(5): 2327 - 2330. [Abstract] [Full Text] [PDF]

				U HELWIG, K M LAMMERS, P GIONCHETTI, F RIZZELLO, M CAMPIERI, M UGUCCIONI;, J WEDEMEYER, A LORENTZ, M P MANNS, and S C BISCHOFF MCP-3 in inflammatory bowel disease Reply Gut, July 1, 2000; 47(1): 155 - 155. [Full Text] [PDF]

This Article Abstract Full Text (PDF) Purchase Article View Shopping Cart Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Uguccioni, M. Articles by Baggiolini, M. Search for Related Content PubMed PubMed Citation Articles by Uguccioni, M. Articles by Baggiolini, M.